Buzzy (Numbing Device) Net Worth Shark Tank Update 2025

Dr. Amy Baxter created Buzzy to assist children who are afraid of needles. After her son had a negative experience with his vaccinations, Dr. Amy sought to create something to alleviate the discomfort.

She developed Buzzy, a gadget that numbs the skin using coldness and vibration. It’s a compact gadget that can be utilized at home or in healthcare facilities. Buzzy aids in alleviating the discomfort from injections or other rapid procedures.

Dr. Amy appeared on Shark Tank asking for $500,000 in exchange for 5% of her business. She wished the Sharks would aid her development. Will the entrepreneur get a deal on Shark Tank? Check out the Buzzy update to find out!  

Buzzy (Numbing Device) Net Worth Shark Tank Update 2025

Dr. Amy Baxter went on Shark Tank asking for $500,000 for 5% of her company. This meant she thought her business was worth $10,000,000. She made a deal with Mark Cuban for $500,000 for 12%, lowering the valuation to $4,166,667. The episode was aired on January 31, 2014. The medical pain relief device continues to be used in hospitals and clinics under the Pain Care Labs brand. Using the default 10% yearly growth method, the current net worth of Buzzy is estimated to be around $8–10 million in 2025.

After Dr. Amy Baxter appeared on Shark Tank Buzzy did not get a deal. The Sharks had doubts about her strategy and the way she planned to grow the business. However, the product continued to succeed. Since her appearance on the show, Buzzy has continued to grow. It made over $1 million in sales and had a net profit of $660,000.

The following year the company projected sales of $2.5 million. As of 2023 Buzzy is still in business and continues to sell products online and in stores like CVS. The company has expanded its product line. They now offer pain relief options for people of all ages. Buzzy has earned a solid reputation in the healthcare industry. Despite not getting a deal Buzzy has found success and is doing well.

No Buzzy did not get a deal on Shark Tank. Dr. Amy Baxter asked for $500,000 in exchange for 5% of the company. The Sharks were interested in the product but had concerns. Barbara Corcoran didn’t think the cost to get the device into hospitals was worth the investment. Kevin O’Leary didn’t agree with Dr. Amy’s distribution plan. Lori Greiner thought Amy should focus more on selling to medical clinics. She felt retail sales were not in the right direction.

Mark Cuban and Robert Herjavec also had doubts. They didn’t think Dr. Amy’s business plan was ready for the next step. Amy rejected their offers. She said she already had other offers for $500,000. In the end, the Sharks decided not to invest.

Shark(s) NameOffer & DemandCounter OfferAccepted?
Lori GreinerOutN/AN/A
Robert Herjavec$250,000 (combined offer with Kevin)N/AN/A
Kevin O’Leary$500,000 for 20% equityN/AN/A
Barbara CorcoranOutN/AN/A
Mark Cuban$500,000 for 20% equityN/AN/A

Buzzy (Numbing Device) Shark Tank pitch

Dr. Amy Baxter was inspired to create Buzzy based on her son’s experiences with getting shots. She observed the extent of pain and fear that children experienced during vaccinations. Following her son’s negative experience, Dr. Amy aimed to discover a method to assist children. She began seeking a way to lessen the discomfort of injections. After extensive research, she discovered that using cold and vibration together could desensitize the skin.

This approach was more effective than any other she had attempted. She subsequently developed the Buzzy device. The gadget employs a tiny vibrating cold pack to anesthetize the skin and lessen the discomfort from injections. It is simple to operate and convenient to carry. Amy aimed to develop a product that would assist both children and adults experiencing needle pain. She aimed to reduce the stress associated with receiving vaccinations.

However, the trip was challenging. Dr. Amy encountered several difficulties during the initial phases of creating Buzzy. She needed to identify the appropriate technology to build the device. She also needed to determine how to deliver it to those who required it. She put in a lot of effort to ensure the product was both affordable and effective. Dr. Amy faced numerous challenges yet she never lost hope.

She was resolute in her desire to assist others. Today, Buzzy is a thriving product that assists thousands of individuals annually.        

Dr. Amy Baxter stepped into the Shark Tank pitch room with a distinct objective. She aimed to provide a remedy for individuals who feared needles. Her product was Buzzy a tiny gadget that numbs the skin using cold and vibrations. She described how Buzzy operates by merging two elements: cold and vibration. She informed the Sharks that this mixture might lessen the discomfort of injections.

Amy suggested that Buzzy could assist kids and grown-ups in experiencing reduced pain during shots or tattoos. She requested $500,000 in exchange for 5% of the business. Amy clarified that the product was already generating revenue. Indeed she was on pace to achieve $1 million in sales for the year. She further estimated that sales might hit $2.5 million next year. Amy had sold more than 33,000 units and the product was accessible for home use.

The retail cost was approximately $40 for one Buzzy unit. The Sharks paid close attention to Amy’s presentation. They were impressed by the product itself but they had inquiries regarding the business model.         

The Sharks were intrigued by Buzzy and its functionality. They posed numerous inquiries to Amy regarding the product. Mark Cuban was interested in learning how Dr. Amy intended to market Buzzy. He inquired about the expense involved in introducing the device to medical clinics. He was also curious about her strategy for expanding the business. Dr. Amy stated that she intended to market the device straight to hospitals and clinics.

She intended to market it in stores such as CVS. However, Mark believed that was not a wise idea. He believed the expenses to bring Buzzy into clinics would be excessive. Kevin O’Leary expressed worries regarding Amy’s approach to managing distribution. He believed she lacked a definite plan. He felt concerned about the risks associated with investing in Buzzy. Lori Greiner concurred with Kevin.

She mentioned that Amy ought to concentrate on selling to medical clinics instead of retail. Robert Herjavec experienced uncertainties as well. He believed Amy wasn’t ready for the next phase in expanding the business.            

In the end, none of the Sharks decided to make an offer. They all had concerns about the product and the business plan. Kevin O’Leary offered $500,000 for 20% of the company but Amy rejected the offer. She said that she already had other offers for $500,000 outside of Shark Tank. Robert Herjavec also offered to invest but he only offered $250,000. He suggested that he and Kevin go in together on the deal but Amy turned down that offer too.

Mark Cuban also offered $500,000 for 20% but Amy declined that offer as well. In the end, Buzzy left Shark Tank without a deal. The Sharks liked the product but did not think the business plan was ready for such a big investment.          

What Went Wrong With Buzzy On Shark Tank?

There were several reasons why Buzzy didn’t get a deal on Shark Tank. The Sharks were interested in the product but had doubts about the business plan. Barbara Corcoran didn’t think the cost to get the device into hospitals and clinics was worth the investment. Kevin O’Leary didn’t think the distribution plan was solid. Lori Greiner also thought that Amy should focus more on medical clinics instead of retail stores.

Robert Herjavec and Mark Cuban were both concerned about Amy’s lack of preparation for the next stage of growth. Amy’s pitch did not convince the Sharks that the company was ready for investment. As a result, none of the Sharks made an offer. 

Product Availability

Buzzy is available for purchase online and in some stores. You can buy Buzzy on the official website and on Amazon. It is also available in select CVS stores. The product comes in different versions to meet different needs. The entry-level version is designed for home use. It costs around $40. The company has expanded its product line to offer more pain relief options. These products are available for people of all ages.

The company is still growing and plans to continue offering drug-free solutions for pain relief. The products are easy to use and offer a non-invasive way to manage pain. The Buzzy website offers more information about the products and how to buy them.

Conclusion

Buzzy’s journey on Shark Tank didn’t end with a deal. However, Dr. Amy Baxter’s product has continued to grow. Buzzy is still going strong and helping people manage pain. The company has expanded its product line and continues to make sales. The Buzzy device is available online and in stores like CVS.